Nasrin Zare, Shaghayegh Haghjooy Javanmard, V. Mehrzad, N. Eskandari, A. Andalib
{"title":"难治性/复发性或反应性弥漫性大b细胞淋巴瘤患者血浆来源外泌体对自然杀伤细胞功能的影响","authors":"Nasrin Zare, Shaghayegh Haghjooy Javanmard, V. Mehrzad, N. Eskandari, A. Andalib","doi":"10.22074/cellj.2020.6550","DOIUrl":null,"url":null,"abstract":"Objective The purpose of this study was to investigate effect of plasma-derived exosomes of refractory/relapsed or responsive diffuse large B-cell lymphoma (DLBCL) patients on natural killer (NK) cell functions. Materials and Methods In this cross-sectional and experimental study, NK cells were purified from responsive patients (n=10) or refractory/relapsed patients (n=12) and healthy donors (n=12). NK cells were treated with plasma-derived exosomes of responsive or refractory/relapsed patients. We examined the expression levels of hsa-miR-155-5p, hsa- let-7g-5p, INPP5D (SHIP-1) and SOCS-1 in NK cells quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Percentages of NK cells expressing CD69, NKG2D and CD16, NK cell cytotoxicity and NK cell proliferation (using flow-cytometry) as well as interferon-gamma (IFN-γ) level in the supernatant of NK cells using ELISA were also investigated. Results We observed an increased level of hsa-miR-155-5p and a decreased level of SOCS-1 in NK cells treated with exosomes compared to untreated NK cell in healthy donors and DLBCL patients. An increase in hsa-miR-155-5p level was associated with an increased level of IFN-γ in healthy donors. The decreased levels of hsa-let-7g-5p were observed in NK cells treated with exosomes in comparison with untreated NK cells in DLBCL patients (P<0.05). There was no significant difference in the percentage of CD69+NK cells and NKG2D+ NK cells in the absence or presence of exosomes of DLBCL patients in each group. Furthermore, we observed significant reduction of NK cell proliferation in DLBCL patients and healthy donors in the presence of exosomes of refractory/relapsed patients (P<0.05). A significant decrease was observed in cytotoxicity of NK cell in patients with DLBCL treated with exosomes of responsive patients. Conclusion Our findings demonstrated adverse effect of plasma-derived exosomes of DLBCL patients on some functions of NK cell. It was also determined that low NK cell count might be associated with impaired response to R-CHOP and an increased recurrence risk of cancer.","PeriodicalId":9692,"journal":{"name":"Cell Journal (Yakhteh)","volume":"125 1","pages":"40 - 54"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":"{\"title\":\"Effect of Plasma-Derived Exosomes of Refractory/Relapsed or Responsive Patients with Diffuse Large B-Cell Lymphoma on Natural Killer Cells Functions\",\"authors\":\"Nasrin Zare, Shaghayegh Haghjooy Javanmard, V. Mehrzad, N. Eskandari, A. Andalib\",\"doi\":\"10.22074/cellj.2020.6550\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective The purpose of this study was to investigate effect of plasma-derived exosomes of refractory/relapsed or responsive diffuse large B-cell lymphoma (DLBCL) patients on natural killer (NK) cell functions. Materials and Methods In this cross-sectional and experimental study, NK cells were purified from responsive patients (n=10) or refractory/relapsed patients (n=12) and healthy donors (n=12). NK cells were treated with plasma-derived exosomes of responsive or refractory/relapsed patients. We examined the expression levels of hsa-miR-155-5p, hsa- let-7g-5p, INPP5D (SHIP-1) and SOCS-1 in NK cells quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Percentages of NK cells expressing CD69, NKG2D and CD16, NK cell cytotoxicity and NK cell proliferation (using flow-cytometry) as well as interferon-gamma (IFN-γ) level in the supernatant of NK cells using ELISA were also investigated. Results We observed an increased level of hsa-miR-155-5p and a decreased level of SOCS-1 in NK cells treated with exosomes compared to untreated NK cell in healthy donors and DLBCL patients. An increase in hsa-miR-155-5p level was associated with an increased level of IFN-γ in healthy donors. The decreased levels of hsa-let-7g-5p were observed in NK cells treated with exosomes in comparison with untreated NK cells in DLBCL patients (P<0.05). There was no significant difference in the percentage of CD69+NK cells and NKG2D+ NK cells in the absence or presence of exosomes of DLBCL patients in each group. Furthermore, we observed significant reduction of NK cell proliferation in DLBCL patients and healthy donors in the presence of exosomes of refractory/relapsed patients (P<0.05). A significant decrease was observed in cytotoxicity of NK cell in patients with DLBCL treated with exosomes of responsive patients. Conclusion Our findings demonstrated adverse effect of plasma-derived exosomes of DLBCL patients on some functions of NK cell. It was also determined that low NK cell count might be associated with impaired response to R-CHOP and an increased recurrence risk of cancer.\",\"PeriodicalId\":9692,\"journal\":{\"name\":\"Cell Journal (Yakhteh)\",\"volume\":\"125 1\",\"pages\":\"40 - 54\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cell Journal (Yakhteh)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22074/cellj.2020.6550\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Journal (Yakhteh)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22074/cellj.2020.6550","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8
摘要
目的探讨难治性/复发性或反应性弥漫性大b细胞淋巴瘤(DLBCL)患者血浆源性外泌体对自然杀伤细胞(NK)功能的影响。材料和方法在这项横断面和实验研究中,从反应性患者(n=10)或难治性/复发患者(n=12)和健康供者(n=12)中纯化NK细胞。NK细胞用反应性或难治性/复发患者的血浆来源外泌体处理。我们检测了hsa- mir -155-5p、hsa- let-7g-5p、INPP5D (SHIP-1)和SOCS-1在NK细胞中的表达水平。用ELISA法检测NK细胞上清液中表达CD69、NKG2D和CD16的NK细胞百分比、NK细胞毒性和NK细胞增殖(流式细胞术)以及干扰素γ (IFN-γ)水平。结果我们观察到,与健康供体和DLBCL患者的NK细胞相比,外泌体处理的NK细胞中hsa-miR-155-5p水平升高,SOCS-1水平降低。健康供体中hsa-miR-155-5p水平升高与IFN-γ水平升高相关。与未处理NK细胞相比,外泌体处理NK细胞中hsa-let-7g-5p水平降低(P<0.05)。两组DLBCL患者外泌体存在或缺失时CD69+NK细胞和NKG2D+ NK细胞的百分比差异无统计学意义。此外,我们观察到在难治性/复发患者的外泌体存在时,DLBCL患者和健康供者的NK细胞增殖显著减少(P<0.05)。反应性患者外泌体治疗的DLBCL患者NK细胞毒性显著降低。结论DLBCL患者血浆源性外泌体对NK细胞的某些功能有不良影响。研究还确定,低NK细胞计数可能与R-CHOP反应受损和癌症复发风险增加有关。
Effect of Plasma-Derived Exosomes of Refractory/Relapsed or Responsive Patients with Diffuse Large B-Cell Lymphoma on Natural Killer Cells Functions
Objective The purpose of this study was to investigate effect of plasma-derived exosomes of refractory/relapsed or responsive diffuse large B-cell lymphoma (DLBCL) patients on natural killer (NK) cell functions. Materials and Methods In this cross-sectional and experimental study, NK cells were purified from responsive patients (n=10) or refractory/relapsed patients (n=12) and healthy donors (n=12). NK cells were treated with plasma-derived exosomes of responsive or refractory/relapsed patients. We examined the expression levels of hsa-miR-155-5p, hsa- let-7g-5p, INPP5D (SHIP-1) and SOCS-1 in NK cells quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Percentages of NK cells expressing CD69, NKG2D and CD16, NK cell cytotoxicity and NK cell proliferation (using flow-cytometry) as well as interferon-gamma (IFN-γ) level in the supernatant of NK cells using ELISA were also investigated. Results We observed an increased level of hsa-miR-155-5p and a decreased level of SOCS-1 in NK cells treated with exosomes compared to untreated NK cell in healthy donors and DLBCL patients. An increase in hsa-miR-155-5p level was associated with an increased level of IFN-γ in healthy donors. The decreased levels of hsa-let-7g-5p were observed in NK cells treated with exosomes in comparison with untreated NK cells in DLBCL patients (P<0.05). There was no significant difference in the percentage of CD69+NK cells and NKG2D+ NK cells in the absence or presence of exosomes of DLBCL patients in each group. Furthermore, we observed significant reduction of NK cell proliferation in DLBCL patients and healthy donors in the presence of exosomes of refractory/relapsed patients (P<0.05). A significant decrease was observed in cytotoxicity of NK cell in patients with DLBCL treated with exosomes of responsive patients. Conclusion Our findings demonstrated adverse effect of plasma-derived exosomes of DLBCL patients on some functions of NK cell. It was also determined that low NK cell count might be associated with impaired response to R-CHOP and an increased recurrence risk of cancer.